Evaluation Opioid Trends

In part 3 of our 2023 drug trends series, we’re evaluating workers’ comp opioid patterns and the strategies being used to continue their decline in use and manage their risks.

Infographic Summary

Opioids continue to represent a decreasing proportion of overall scripts and costs, with favorable trends seen in important markers such as morphine equivalent dose (MED), duration of use, and access to guideline-supported measures including medication-assisted treatment (MAT) and overdose rescue medication (naloxone). Part 3 of our annual drug trends series focuses on opioid trends and the risk management strategies driving the continued decline in opioid Use.

To view future installments of the drug trends series, be sure to visit our drug trends page.

Register to download the full content


To learn more from Enlyte, please visit their website.

Enlyte is the parent brand of Mitchell | Genex | Coventry, a leader in cost-containment technology, independent medical exams (IME), provider and specialty networks, case management services, pharmacy benefit and disability management. The three businesses have recently aligned their joint industry expertise and advanced technology solutions into a combined organization of nearly 6,000 associates committed to simplifying and optimizing property, casualty and disability claims processes and services.

More from Risk & Insurance